Review



human tgct embryonal carcinoma ec cell lines nt2 d1  (ATCC)


Bioz Verified Symbol ATCC is a verified supplier
Bioz Manufacturer Symbol ATCC manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 95

    Structured Review

    ATCC human tgct embryonal carcinoma ec cell lines nt2 d1
    Cisplatin-resistant <t>TGCT</t> cells have a less robust transcriptional response to cisplatin compared to parental cells. ( A ) Volcano plots of the cisplatin response of 2102EP parental and three independently derived cisplatin-resistant cell derivatives. ( B ) Volcano plots of the cisplatin response <t>of</t> <t>NT2/D1</t> parental and two independently derived cisplatin-resistant cell derivatives. ( C ) Volcano plots of the cisplatin response of 833K parental and two independently derived cisplatin-resistant cell derivatives. ( D ) Number of genes upregulated and downregulated (>1.3 fold change and an FDR < 0.01) after cisplatin treatment in indicated parental and resistant cells.
    Human Tgct Embryonal Carcinoma Ec Cell Lines Nt2 D1, supplied by ATCC, used in various techniques. Bioz Stars score: 95/100, based on 136 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/human tgct embryonal carcinoma ec cell lines nt2 d1/product/ATCC
    Average 95 stars, based on 136 article reviews
    human tgct embryonal carcinoma ec cell lines nt2 d1 - by Bioz Stars, 2026-03
    95/100 stars

    Images

    1) Product Images from "Comparative Analysis of the Transcriptomic Response to Cisplatin in Drug-Sensitive and Drug-Resistant Testicular Germ Cell Tumors"

    Article Title: Comparative Analysis of the Transcriptomic Response to Cisplatin in Drug-Sensitive and Drug-Resistant Testicular Germ Cell Tumors

    Journal: Cancers

    doi: 10.3390/cancers18040575

    Cisplatin-resistant TGCT cells have a less robust transcriptional response to cisplatin compared to parental cells. ( A ) Volcano plots of the cisplatin response of 2102EP parental and three independently derived cisplatin-resistant cell derivatives. ( B ) Volcano plots of the cisplatin response of NT2/D1 parental and two independently derived cisplatin-resistant cell derivatives. ( C ) Volcano plots of the cisplatin response of 833K parental and two independently derived cisplatin-resistant cell derivatives. ( D ) Number of genes upregulated and downregulated (>1.3 fold change and an FDR < 0.01) after cisplatin treatment in indicated parental and resistant cells.
    Figure Legend Snippet: Cisplatin-resistant TGCT cells have a less robust transcriptional response to cisplatin compared to parental cells. ( A ) Volcano plots of the cisplatin response of 2102EP parental and three independently derived cisplatin-resistant cell derivatives. ( B ) Volcano plots of the cisplatin response of NT2/D1 parental and two independently derived cisplatin-resistant cell derivatives. ( C ) Volcano plots of the cisplatin response of 833K parental and two independently derived cisplatin-resistant cell derivatives. ( D ) Number of genes upregulated and downregulated (>1.3 fold change and an FDR < 0.01) after cisplatin treatment in indicated parental and resistant cells.

    Techniques Used: Derivative Assay

    p53/TFRC1/MYC target genes are associated with disease-free survival in TGCT patients. High expression of a partially overlapping subset of genes associated with p53 activation and TFRC1 and MYC repression were associated with increased disease-free survival in TGCT patients as assessed by Kaplan–Meier log-rank tests. HR, hazard ratio; CI, confidence interval.
    Figure Legend Snippet: p53/TFRC1/MYC target genes are associated with disease-free survival in TGCT patients. High expression of a partially overlapping subset of genes associated with p53 activation and TFRC1 and MYC repression were associated with increased disease-free survival in TGCT patients as assessed by Kaplan–Meier log-rank tests. HR, hazard ratio; CI, confidence interval.

    Techniques Used: Expressing, Activation Assay



    Similar Products

    95
    ATCC human tgct embryonal carcinoma ec cell lines nt2 d1
    Cisplatin-resistant <t>TGCT</t> cells have a less robust transcriptional response to cisplatin compared to parental cells. ( A ) Volcano plots of the cisplatin response of 2102EP parental and three independently derived cisplatin-resistant cell derivatives. ( B ) Volcano plots of the cisplatin response <t>of</t> <t>NT2/D1</t> parental and two independently derived cisplatin-resistant cell derivatives. ( C ) Volcano plots of the cisplatin response of 833K parental and two independently derived cisplatin-resistant cell derivatives. ( D ) Number of genes upregulated and downregulated (>1.3 fold change and an FDR < 0.01) after cisplatin treatment in indicated parental and resistant cells.
    Human Tgct Embryonal Carcinoma Ec Cell Lines Nt2 D1, supplied by ATCC, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/human tgct embryonal carcinoma ec cell lines nt2 d1/product/ATCC
    Average 95 stars, based on 1 article reviews
    human tgct embryonal carcinoma ec cell lines nt2 d1 - by Bioz Stars, 2026-03
    95/100 stars
      Buy from Supplier

    96
    ATCC human nt2 d1 precursor cells
    Cisplatin-resistant <t>TGCT</t> cells have a less robust transcriptional response to cisplatin compared to parental cells. ( A ) Volcano plots of the cisplatin response of 2102EP parental and three independently derived cisplatin-resistant cell derivatives. ( B ) Volcano plots of the cisplatin response <t>of</t> <t>NT2/D1</t> parental and two independently derived cisplatin-resistant cell derivatives. ( C ) Volcano plots of the cisplatin response of 833K parental and two independently derived cisplatin-resistant cell derivatives. ( D ) Number of genes upregulated and downregulated (>1.3 fold change and an FDR < 0.01) after cisplatin treatment in indicated parental and resistant cells.
    Human Nt2 D1 Precursor Cells, supplied by ATCC, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/human nt2 d1 precursor cells/product/ATCC
    Average 96 stars, based on 1 article reviews
    human nt2 d1 precursor cells - by Bioz Stars, 2026-03
    96/100 stars
      Buy from Supplier

    96
    ATCC human nt2 teratocarcinoma cells
    The post-mortem bipolar disorder (BD) gene expression dataset was created using RNA sequencing (RNAseq) data from post-mortem dorsolateral prefrontal cortex (DLPFC) samples obtained from BD patients and healthy controls (HC). This dataset was used to create gene regulatory networks, which were then compared to a list of genes related to melatonin synthesis, signalling, and degradation using gene set enrichment analysis (GSEA), and to gene regulatory networks for melatonin agonists. The <t>NT2-N</t> gene expression dataset was created using RNAseq libraries prepared from differentiated NT2-N neurons treated with various mood stabilisers for 24 hours. This dataset was then compared to a list of melatonin-related genes using GSEA. [Created by authors with biorender.com ]
    Human Nt2 Teratocarcinoma Cells, supplied by ATCC, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/human nt2 teratocarcinoma cells/product/ATCC
    Average 96 stars, based on 1 article reviews
    human nt2 teratocarcinoma cells - by Bioz Stars, 2026-03
    96/100 stars
      Buy from Supplier

    96
    ATCC human pluripotent nt2 cells
    A Representative morphological features of Neu (neuron-enriched), eA (early astrocytes), and mA (mature astrocytes) cultures. Scale bars always indicate 50 µm. B Immunocytochemical staining for neuronal and astrocytic markers. Each tile scan is composed of 20 images. Supplementary Fig. S5A shows the images without zoomed inserts, while Supplementary Fig. S5B presents additional images of neuronal staining in mA cultures. Scale bars always indicate 100 µm. C Time-dependent changes in the GFAP level upon astrocyte maturation monitored using Western blot with densitometry signals for GFAP normalized to the total protein load per well, as determined by ruthenium staining, with available Supplementary Data F1B and Supplementary Fig. S4. w0 denotes the starting point of maturation after the completion of retinoic acid treatment. D The distribution of cell diameters for eA and mA relative to undifferentiated <t>NT2</t> cells, with n = 25, was calculated using ImageJ software, assuming a circular cell shape. Owing to variance inequality, the Kruskal–Wallis test was used for statistical analysis
    Human Pluripotent Nt2 Cells, supplied by ATCC, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/human pluripotent nt2 cells/product/ATCC
    Average 96 stars, based on 1 article reviews
    human pluripotent nt2 cells - by Bioz Stars, 2026-03
    96/100 stars
      Buy from Supplier

    96
    ATCC nt2 human teratocarcinoma cells
    A Representative morphological features of Neu (neuron-enriched), eA (early astrocytes), and mA (mature astrocytes) cultures. Scale bars always indicate 50 µm. B Immunocytochemical staining for neuronal and astrocytic markers. Each tile scan is composed of 20 images. Supplementary Fig. S5A shows the images without zoomed inserts, while Supplementary Fig. S5B presents additional images of neuronal staining in mA cultures. Scale bars always indicate 100 µm. C Time-dependent changes in the GFAP level upon astrocyte maturation monitored using Western blot with densitometry signals for GFAP normalized to the total protein load per well, as determined by ruthenium staining, with available Supplementary Data F1B and Supplementary Fig. S4. w0 denotes the starting point of maturation after the completion of retinoic acid treatment. D The distribution of cell diameters for eA and mA relative to undifferentiated <t>NT2</t> cells, with n = 25, was calculated using ImageJ software, assuming a circular cell shape. Owing to variance inequality, the Kruskal–Wallis test was used for statistical analysis
    Nt2 Human Teratocarcinoma Cells, supplied by ATCC, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/nt2 human teratocarcinoma cells/product/ATCC
    Average 96 stars, based on 1 article reviews
    nt2 human teratocarcinoma cells - by Bioz Stars, 2026-03
    96/100 stars
      Buy from Supplier

    96
    ATCC human pluripotent nt2 d1 embryonal carcinoma cells
    A Representative morphological features of Neu (neuron-enriched), eA (early astrocytes), and mA (mature astrocytes) cultures. Scale bars always indicate 50 µm. B Immunocytochemical staining for neuronal and astrocytic markers. Each tile scan is composed of 20 images. Supplementary Fig. S5A shows the images without zoomed inserts, while Supplementary Fig. S5B presents additional images of neuronal staining in mA cultures. Scale bars always indicate 100 µm. C Time-dependent changes in the GFAP level upon astrocyte maturation monitored using Western blot with densitometry signals for GFAP normalized to the total protein load per well, as determined by ruthenium staining, with available Supplementary Data F1B and Supplementary Fig. S4. w0 denotes the starting point of maturation after the completion of retinoic acid treatment. D The distribution of cell diameters for eA and mA relative to undifferentiated <t>NT2</t> cells, with n = 25, was calculated using ImageJ software, assuming a circular cell shape. Owing to variance inequality, the Kruskal–Wallis test was used for statistical analysis
    Human Pluripotent Nt2 D1 Embryonal Carcinoma Cells, supplied by ATCC, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/human pluripotent nt2 d1 embryonal carcinoma cells/product/ATCC
    Average 96 stars, based on 1 article reviews
    human pluripotent nt2 d1 embryonal carcinoma cells - by Bioz Stars, 2026-03
    96/100 stars
      Buy from Supplier

    96
    ATCC treatment nt2 human teratocarcinoma cells
    A Representative morphological features of Neu (neuron-enriched), eA (early astrocytes), and mA (mature astrocytes) cultures. Scale bars always indicate 50 µm. B Immunocytochemical staining for neuronal and astrocytic markers. Each tile scan is composed of 20 images. Supplementary Fig. S5A shows the images without zoomed inserts, while Supplementary Fig. S5B presents additional images of neuronal staining in mA cultures. Scale bars always indicate 100 µm. C Time-dependent changes in the GFAP level upon astrocyte maturation monitored using Western blot with densitometry signals for GFAP normalized to the total protein load per well, as determined by ruthenium staining, with available Supplementary Data F1B and Supplementary Fig. S4. w0 denotes the starting point of maturation after the completion of retinoic acid treatment. D The distribution of cell diameters for eA and mA relative to undifferentiated <t>NT2</t> cells, with n = 25, was calculated using ImageJ software, assuming a circular cell shape. Owing to variance inequality, the Kruskal–Wallis test was used for statistical analysis
    Treatment Nt2 Human Teratocarcinoma Cells, supplied by ATCC, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/treatment nt2 human teratocarcinoma cells/product/ATCC
    Average 96 stars, based on 1 article reviews
    treatment nt2 human teratocarcinoma cells - by Bioz Stars, 2026-03
    96/100 stars
      Buy from Supplier

    Image Search Results


    Cisplatin-resistant TGCT cells have a less robust transcriptional response to cisplatin compared to parental cells. ( A ) Volcano plots of the cisplatin response of 2102EP parental and three independently derived cisplatin-resistant cell derivatives. ( B ) Volcano plots of the cisplatin response of NT2/D1 parental and two independently derived cisplatin-resistant cell derivatives. ( C ) Volcano plots of the cisplatin response of 833K parental and two independently derived cisplatin-resistant cell derivatives. ( D ) Number of genes upregulated and downregulated (>1.3 fold change and an FDR < 0.01) after cisplatin treatment in indicated parental and resistant cells.

    Journal: Cancers

    Article Title: Comparative Analysis of the Transcriptomic Response to Cisplatin in Drug-Sensitive and Drug-Resistant Testicular Germ Cell Tumors

    doi: 10.3390/cancers18040575

    Figure Lengend Snippet: Cisplatin-resistant TGCT cells have a less robust transcriptional response to cisplatin compared to parental cells. ( A ) Volcano plots of the cisplatin response of 2102EP parental and three independently derived cisplatin-resistant cell derivatives. ( B ) Volcano plots of the cisplatin response of NT2/D1 parental and two independently derived cisplatin-resistant cell derivatives. ( C ) Volcano plots of the cisplatin response of 833K parental and two independently derived cisplatin-resistant cell derivatives. ( D ) Number of genes upregulated and downregulated (>1.3 fold change and an FDR < 0.01) after cisplatin treatment in indicated parental and resistant cells.

    Article Snippet: The human TGCT embryonal carcinoma (EC) cell lines NT2/D1, 833K, and 2102EP were obtained from ATCC.

    Techniques: Derivative Assay

    p53/TFRC1/MYC target genes are associated with disease-free survival in TGCT patients. High expression of a partially overlapping subset of genes associated with p53 activation and TFRC1 and MYC repression were associated with increased disease-free survival in TGCT patients as assessed by Kaplan–Meier log-rank tests. HR, hazard ratio; CI, confidence interval.

    Journal: Cancers

    Article Title: Comparative Analysis of the Transcriptomic Response to Cisplatin in Drug-Sensitive and Drug-Resistant Testicular Germ Cell Tumors

    doi: 10.3390/cancers18040575

    Figure Lengend Snippet: p53/TFRC1/MYC target genes are associated with disease-free survival in TGCT patients. High expression of a partially overlapping subset of genes associated with p53 activation and TFRC1 and MYC repression were associated with increased disease-free survival in TGCT patients as assessed by Kaplan–Meier log-rank tests. HR, hazard ratio; CI, confidence interval.

    Article Snippet: The human TGCT embryonal carcinoma (EC) cell lines NT2/D1, 833K, and 2102EP were obtained from ATCC.

    Techniques: Expressing, Activation Assay

    The post-mortem bipolar disorder (BD) gene expression dataset was created using RNA sequencing (RNAseq) data from post-mortem dorsolateral prefrontal cortex (DLPFC) samples obtained from BD patients and healthy controls (HC). This dataset was used to create gene regulatory networks, which were then compared to a list of genes related to melatonin synthesis, signalling, and degradation using gene set enrichment analysis (GSEA), and to gene regulatory networks for melatonin agonists. The NT2-N gene expression dataset was created using RNAseq libraries prepared from differentiated NT2-N neurons treated with various mood stabilisers for 24 hours. This dataset was then compared to a list of melatonin-related genes using GSEA. [Created by authors with biorender.com ]

    Journal: bioRxiv

    Article Title: Investigating the role of melatonin in bipolar disorder using transcriptomics

    doi: 10.1101/2025.09.03.673928

    Figure Lengend Snippet: The post-mortem bipolar disorder (BD) gene expression dataset was created using RNA sequencing (RNAseq) data from post-mortem dorsolateral prefrontal cortex (DLPFC) samples obtained from BD patients and healthy controls (HC). This dataset was used to create gene regulatory networks, which were then compared to a list of genes related to melatonin synthesis, signalling, and degradation using gene set enrichment analysis (GSEA), and to gene regulatory networks for melatonin agonists. The NT2-N gene expression dataset was created using RNAseq libraries prepared from differentiated NT2-N neurons treated with various mood stabilisers for 24 hours. This dataset was then compared to a list of melatonin-related genes using GSEA. [Created by authors with biorender.com ]

    Article Snippet: This dataset consists of RNAseq data collected from human NT2 teratocarcinoma cells (ATCC, United States; RRID: CVCL_0034).

    Techniques: Gene Expression, RNA Sequencing

    A Representative morphological features of Neu (neuron-enriched), eA (early astrocytes), and mA (mature astrocytes) cultures. Scale bars always indicate 50 µm. B Immunocytochemical staining for neuronal and astrocytic markers. Each tile scan is composed of 20 images. Supplementary Fig. S5A shows the images without zoomed inserts, while Supplementary Fig. S5B presents additional images of neuronal staining in mA cultures. Scale bars always indicate 100 µm. C Time-dependent changes in the GFAP level upon astrocyte maturation monitored using Western blot with densitometry signals for GFAP normalized to the total protein load per well, as determined by ruthenium staining, with available Supplementary Data F1B and Supplementary Fig. S4. w0 denotes the starting point of maturation after the completion of retinoic acid treatment. D The distribution of cell diameters for eA and mA relative to undifferentiated NT2 cells, with n = 25, was calculated using ImageJ software, assuming a circular cell shape. Owing to variance inequality, the Kruskal–Wallis test was used for statistical analysis

    Journal: Cellular & Molecular Biology Letters

    Article Title: NT2-derived astrocyte–neuron co-culture reflects physiological relevance and offers research validity

    doi: 10.1186/s11658-025-00765-z

    Figure Lengend Snippet: A Representative morphological features of Neu (neuron-enriched), eA (early astrocytes), and mA (mature astrocytes) cultures. Scale bars always indicate 50 µm. B Immunocytochemical staining for neuronal and astrocytic markers. Each tile scan is composed of 20 images. Supplementary Fig. S5A shows the images without zoomed inserts, while Supplementary Fig. S5B presents additional images of neuronal staining in mA cultures. Scale bars always indicate 100 µm. C Time-dependent changes in the GFAP level upon astrocyte maturation monitored using Western blot with densitometry signals for GFAP normalized to the total protein load per well, as determined by ruthenium staining, with available Supplementary Data F1B and Supplementary Fig. S4. w0 denotes the starting point of maturation after the completion of retinoic acid treatment. D The distribution of cell diameters for eA and mA relative to undifferentiated NT2 cells, with n = 25, was calculated using ImageJ software, assuming a circular cell shape. Owing to variance inequality, the Kruskal–Wallis test was used for statistical analysis

    Article Snippet: Human pluripotent NT2 cells (ATCC; NTERA-2 cl.D1 cell line, ATCC-CRL-1973) were maintained as previously described [ – ], with certain modifications.

    Techniques: Staining, Western Blot, Software

    A Principal component analysis (PCA) of proteomic data [log 2 label-free quantification (LFQ)] for the studied cell types. The PCA plot represents 3827 proteins (meeting the condition of having LFQ values present in 70% of all samples) with biological replicates, indicating clear proteomic profile differences between Neu (neuron-enriched), eA (early astrocytes), mA (mature astrocytes), and NT2 (undifferentiated) cells. B Hierarchical clustering and a heatmap. The 2145 proteins whose amount significantly differed between the four cell types [ANOVA permutation based false discovery rate (FDR) < 0.0001] are represented in the heatmap. C Volcano plots of the differentially expressed proteins (DEPs). The red and blue dots represent significantly upregulated and downregulated DEPs, respectively. The horizontal dotted line represents −log 10 ANOVA p -value ≥ 4; vertical dashed lines indicate fold change |log 2 FC|≥ 1

    Journal: Cellular & Molecular Biology Letters

    Article Title: NT2-derived astrocyte–neuron co-culture reflects physiological relevance and offers research validity

    doi: 10.1186/s11658-025-00765-z

    Figure Lengend Snippet: A Principal component analysis (PCA) of proteomic data [log 2 label-free quantification (LFQ)] for the studied cell types. The PCA plot represents 3827 proteins (meeting the condition of having LFQ values present in 70% of all samples) with biological replicates, indicating clear proteomic profile differences between Neu (neuron-enriched), eA (early astrocytes), mA (mature astrocytes), and NT2 (undifferentiated) cells. B Hierarchical clustering and a heatmap. The 2145 proteins whose amount significantly differed between the four cell types [ANOVA permutation based false discovery rate (FDR) < 0.0001] are represented in the heatmap. C Volcano plots of the differentially expressed proteins (DEPs). The red and blue dots represent significantly upregulated and downregulated DEPs, respectively. The horizontal dotted line represents −log 10 ANOVA p -value ≥ 4; vertical dashed lines indicate fold change |log 2 FC|≥ 1

    Article Snippet: Human pluripotent NT2 cells (ATCC; NTERA-2 cl.D1 cell line, ATCC-CRL-1973) were maintained as previously described [ – ], with certain modifications.

    Techniques: Quantitative Proteomics